Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


1 Am J Med
2 Antimicrob Agents Chemother
2 HIV Med
10 J Acquir Immune Defic Syndr
3 J Virol
2 Lancet
1 Nature
1 Pediatr Infect Dis J
3 PLoS Med
6 PLoS One
1 Vaccine


  1. QU Y, Weinstein A, Wang Z, Cheng Y, et al
    Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy.
    AIDS. 2021 Sep 13. pii: 00002030-900000000-96316.
    >> Share

  2. N'TAKPE JB, Gabillard D, Moh R, Gardiennet E, et al
    Elite and viremic HIV-1 controllers in West Africa.
    AIDS. 2021 Sep 14. pii: 00002030-900000000-96315.
    >> Share

  3. STENGER MR, Pathela P, Schumacher C, Burghardt N, et al
    Trends in HIV prevalence by self-report among MSM diagnosed and 1 reported with gonorrhea in six U.S. jurisdictions, 2010-2019.
    AIDS. 2021 Sep 10. pii: 00002030-900000000-96317.
    >> Share

    Am J Med

  4. APPA A, Adamo M, Le S, Davis J, et al
    Patient-Directed Discharges Among Persons Who Use Drugs Hospitalized with Invasive S. aureus Infections: Opportunities for Improvement.
    Am J Med. 2021 Sep 8. pii: S0002-9343(21)00569.
    >> Share

    Antimicrob Agents Chemother

  5. ANKROM W, Jackson Rudd D, Schaeffer A, Panebianco D, et al
    Pharmacokinetic and Safety Profile of the Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV.
    Antimicrob Agents Chemother. 2021 Sep 13:AAC0093521. doi: 10.1128/AAC.00935.
    >> Share

  6. CILENTO ME, Reeve AB, Michailidis E, Ilina TV, et al
    Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA) Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor Resistant-Strains.
    Antimicrob Agents Chemother. 2021 Sep 13:AAC0116721. doi: 10.1128/AAC.01167.
    >> Share

    HIV Med

  7. VENKATESH KK, Edmonds A, Westreich D, Dionne-Odom J, et al
    Associations between HIV, antiretroviral therapy and preterm birth in the US Women's Interagency HIV Study, 1995-2018: a prospective cohort.
    HIV Med. 2021 Sep 12. doi: 10.1111/hiv.13171.
    >> Share

  8. BONOU M, Kapelios CJ, Protogerou AD, Mavrogeni S, et al
    Cardiac adiposity as a modulator of cardiovascular disease in HIV.
    HIV Med. 2021 Sep 12. doi: 10.1111/hiv.13166.
    >> Share

    J Acquir Immune Defic Syndr

  9. ORKIN C, Ajana F, Kityo C, Koenig E, et al
    Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95811.
    >> Share

  10. LEMOS MP, Nandi V, Dragavon J, Fleming I, et al
    HIV-1 Nucleic Acids Identify Rectal HIV Exposures in Self-Collected Rectal Swabs, Whereas Y-Chromosome Single Tandem Repeat Mixtures Are Not Reliable Biomarkers of Condomless Receptive Anal Intercourse.
    J Acquir Immune Defic Syndr. 2021;88:138-148.
    >> Share

  11. HULL SJ, Tessema H, Thuku J, Scott RK, et al
    Providers PrEP: Identifying Primary Health care Providers' Biases as Barriers to Provision of Equitable PrEP Services.
    J Acquir Immune Defic Syndr. 2021;88:165-172.
    >> Share

  12. WOMACK JA, Murphy TE, Ramsey C, Bathulapalli H, et al
    Brief Report: Are Serious Falls Associated With Subsequent Fragility Fractures Among Veterans Living With HIV?
    J Acquir Immune Defic Syndr. 2021;88:192-196.
    >> Share

  13. CAMPBELL L, Barbini B, Burling K, Cromarty B, et al
    Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate.
    J Acquir Immune Defic Syndr. 2021;88:214-219.
    >> Share

  14. ALESSANDRI-GRADT E, Unal G, Baron A, Leoz M, et al
    Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O Variants.
    J Acquir Immune Defic Syndr. 2021;88:220-227.
    >> Share

  15. DELLE DONNE V, Massaroni V, Ciccarelli N, Lombardi F, et al
    Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88:e11-e14.
    >> Share

  16. SORENSEN EW, Gelpi M, Knudsen AD, Benfield T, et al
    Switch To Insti, But Not Long-Term Stable Insti, Is Associated With Excess Weight Gain In People Living With Hiv.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95805.
    >> Share

  17. HOGH J, Gelpi M, Skovsgaard MH, Afzal S, et al
    HIV infection is associated with type 2 diabetes mellitus.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95806.
    >> Share

  18. MURNANE PM, Ayieko J, Vittinghoff E, Gandhi M, et al
    Machine learning algorithms using routinely collected data do not adequately predict viremia to inform targeted services in postpartum women living with HIV.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95807.
    >> Share

    J Virol

  19. BANDARRA S, Miyagi E, Ribeiro AC, Goncalves J, et al
    APOBEC3B potently restricts HIV-2 but not HIV-1 in a Vif-dependent manner.
    J Virol. 2021 Sep 15:JVI0117021. doi: 10.1128/JVI.01170.
    >> Share

  20. KUSE N, Murakoshi H, Akahoshi T, Chikata T, et al
    Collaboration of a detrimental HLA-B*35:01 allele with HLA-A*24:02 in co-evolution of HIV-1 with T-cells leading to poorer clinical outcomes.
    J Virol. 2021 Sep 15:JVI0125921. doi: 10.1128/JVI.01259.
    >> Share

  21. IMAMICHI T, Bernbaum JG, Laverdure S, Yang J, et al
    Natural Occurring Polymorphisms in HIV-1 Integrase and RNase H Regulate Viral Release and Autoprocessing.
    J Virol. 2021 Sep 15:JVI0132321. doi: 10.1128/JVI.01323.
    >> Share


  22. DAVIDSON KW, Barry MJ, Mangione CM, Cabana M, et al
    Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2021;326:949-956.
    >> Share


  23. CARLINO MS, Larkin J, Long GV
    Immune checkpoint inhibitors in melanoma.
    Lancet. 2021;398:1002-1014.
    >> Share

  24. JAFFAR S, Ramaiya K, Karekezi C, Sewankambo N, et al
    Controlling diabetes and hypertension in sub-Saharan Africa: lessons from HIV programmes.
    Lancet. 2021 Sep 7. pii: S0140-6736(21)01731.
    >> Share


    How COVID is derailing the fight against HIV, TB and malaria.
    Nature. 2021;597:314.
    >> Share

    Pediatr Infect Dis J

  26. ANTERASIAN C, Warr AJ, Lacourse SM, Kinuthia J, et al
    Non-IFNgamma Whole Blood Cytokine Responses to Mycobacterium tuberculosis Antigens in HIV-exposed Infants.
    Pediatr Infect Dis J. 2021;40:922-929.
    >> Share

    PLoS Med

  27. OXLADE O, Rochon H, Campbell JR, Menzies D, et al
    Tuberculosis preventive treatment in people living with HIV-Is the glass half empty or half full?
    PLoS Med. 2021;18:e1003702.
    >> Share

  28. YANES-LANE M, Ortiz-Brizuela E, Campbell JR, Benedetti A, et al
    Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    PLoS Med. 2021;18:e1003738.
    >> Share

  29. UPPAL A, Rahman S, Campbell JR, Oxlade O, et al
    Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003712.
    >> Share

    PLoS One

  30. DEVALRAJU KP, Neela VSK, Krovvidi SS, Vankayalapati R, et al
    Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection.
    PLoS One. 2021;16:e0257185.
    >> Share

  31. HICKEY MD, Ouma GB, Mattah B, Pederson B, et al
    The Kanyakla study: Randomized controlled trial of a microclinic social network intervention for promoting engagement and retention in HIV care in rural western Kenya.
    PLoS One. 2021;16:e0255945.
    >> Share

  32. MATOVU JKB, Bukenya JN, Kasozi D, Kisaka S, et al
    Sexual-risk behaviours and HIV and syphilis prevalence among in- and out-of-school adolescent girls and young women in Uganda: A cross-sectional study.
    PLoS One. 2021;16:e0257321.
    >> Share

  33. ENANE LA, Apondi E, Aluoch J, Bakoyannis G, et al
    Social, economic, and health effects of the COVID-19 pandemic on adolescents retained in or recently disengaged from HIV care in Kenya.
    PLoS One. 2021;16:e0257210.
    >> Share

  34. MOSES SJ, Wachekwa I, Van Ryn C, Grandits G, et al
    The impact of the 2014 Ebola epidemic on HIV disease burden and outcomes in Liberia West Africa.
    PLoS One. 2021;16:e0257049.
    >> Share

  35. STEPHENSON R, Walsh AR, Chavanduka TMD, Sallabank G, et al
    Widespread closure of HIV prevention and care services places youth at higher risk during the COVID-19 pandemic.
    PLoS One. 2021;16:e0249740.
    >> Share


  36. ABREU E SILVA HB, Correa HP, Ribeiro IA, Nascimento VAM, et al
    Impact of six years of routine varicella vaccination on the disease-related hospitalizations at Minas Gerais, Brazil.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01009.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016